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to model complex I dysfunction and its consequences, including 
increased oxidative stress, perturbed calcium homeostasis, and 
reduced ATP (Cassarino et al., 1997; Sheehan et al., 1997; Esteves 
et al., 2008, 2009).
MATERIALS AND METHODS
CHEMICALS AND CELL MEDIA
Paclitaxel (taxol), was obtained from Sigma (St. Louis, MO, USA). 
Optimem medium was obtained from Gibco-Invitrogen. Non-
 dialyzed and dialyzed fetal bovine serum was obtained from Gibco-
Invitrogen. NT2 ρ0 cell growth medium consisted of Optimem 
supplemented with 10% non-dialyzed fetal bovine serum, 200 µg/
ml sodium pyruvate, 150 µg/ml uridine, and 100 IU/ml penicillin 
and 50 µg/ml streptomycin. NT2 cybrid selection medium con-
sisted of Optimem supplemented with 10% dialyzed fetal bovine 
serum and penicillin–streptomycin. Cybrid expansion medium 
consisted of Optimem supplemented with 10% non-dialyzed 
fetal bovine serum and penicillin–streptomycin. Taxol medium 
consisted of cybrid expansion medium with 5 nM taxol, and was 
prepared using a DMSO-taxol stock solution. For all conditions 
tested, control experiments were performed using unsupplemented 
cybrid expansion medium.
HUMAN SUBJECTS
Subject participation was approved through the Institutional 
Review Board of the University Hospital of Coimbra. The two 
sporadic PD subjects, without any nuclear DNA mutation known 
to be relevant to PD, meet Gelb et al. (1999) diagnostic criteria and 
two healthy, age-matched control subject provided 10 ml blood 
samples following written informed consent. Blood was drawn 
directly into tubes containing acid-citrate-dextrose.
INTRODUCTION
Sporadic Parkinson’s disease (PD) pathology is characterized by 
substantia nigra pars compacta neuronal loss, systemic dysfunction 
of the mitochondrial enzyme complex I, and intraneuronal alpha-
synuclein (a-syn) aggregation (Cardoso et al., 2005). While a-syn 
overexpression and mutation cause familial PD, the mechanisms 
that mediate this are unclear (Singleton et al., 2003; Hope et al., 
2004). This is not surprising, as the normal function of a-syn is 
itself poorly characterized.
Recent data indicate a-syn interacts with microtubules to affect 
membrane stability and neuronal plasticity (Lee et  al., 2006). 
Microtubules are highly dynamic tubulin polymers that medi-
ate organelle transport, cell motility, division, and morphology 
(Morris and Hollenbeck, 1995). Conditions that favor incorpora-
tion of tubulin into microtubules reduce free/polymerized tubulin 
ratios, while conditions that retard microtubule formation increase 
this ratio.
The complex I inhibitors rotenone and 1-methyl-4-phenylpy-
ridinium (MPP+) alter microtubule dynamics and increase free 
tubulin/polymerized tubulin ratios (Cappeleti et al., 2005; Ren 
and Feng, 2007). Tubulin, interestingly, induces a-syn ﬁ  brilliza-
tion in yeast, rat brain, and human brain (Alim et al., 2002; Kim 
et al., 2007).
Because complex I dysfunction occurs in PD and may contrib-
ute to a-syn aggregation (Parker et al., 1989; Schapira et al., 1989; 
Lee, 2003) we hypothesized a nexus between complex I dysfunc-
tion, ATP depletion, microtubule disassembly, and a-syn oligomer-
ization might exist. We tested this hypothesis using cytoplasmic 
hybrid (cybrid) cells prepared via the transfer of PD subject plate-
let mitochondria to mitochondrial DNA (mtDNA) depleted (ρ0) 
human NT2 teratocarcinoma cells. PD cybrids have been shown 
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CREATION OF CYBRID CELL LINES AND CELL CULTURE
NT2 ρ0 cells were brieﬂ  y agitated in polyethylene glycol with plate-
lets from the human subjects (Cardoso et al., 2004). Seven days 
after plating the resulting mixture in T75 ﬂ  asks and ρ0 growth 
medium, the medium was changed to cybrid selection medium. 
NT2 ρ0 cells lack intact mtDNA, do not possess a functional 
  electron transport chain (ETC), and are auxotrophic for pyru-
vate and uridine (Swerdlow et  al., 1997; Cardoso et  al., 2004). 
Maintaining cells in selection medium removes ρ0 cells that have 
not repopulated their mtDNA with platelet mtDNA. After selection 
was complete, the resultant cybrid cells were switched to cybrid 
expansion medium.
For taxol, experiments, cybrid cell lines were placed in media 
containing 5 nM taxol. Flasks were maintained in these media at 
37°C, 5% CO2 for 24 h prior to harvesting.
IMMUNOCYTOCHEMISTRY
Cybrid cell lines grown on coverslips in 12 well plates were washed 
twice with PBS and ﬁ  xed for 30 min at room temperature using 4% 
paraformaldehyde. The ﬁ  xed cells were washed again with PBS, per-
meabilized with 0.2% Triton X-100, and blocked with 3% BSA. The 
permeabilized cells were incubated with primary antibody (1:2,000 
monoclonal anti-alpha-tubulin from Sigma; 1:400 monoclonal 
anti-a-syn from Santa Cruz Biotechnology, Inc., Santa Cruz, SA, 
USA, or 1:400 Polyclonal anti-A11 from BioSource International, 
Inc., Flynn Road, Camarillo, CA, USA) for 1 h and then with the 
appropriate secondary antibody (1:250 alexa ﬂ  uor 594 and 488 
from Molecular probes, Eugene, OR, USA). Cells were visualized 
by confocal microscopy.
IMMUNOBLOTTING
Individual cybrid cell lines were scraped in buffer containing 
25 mM HEPES, 1 mM EDTA, 1 mM EGTA, 2 mM MgCl2, protease 
inhibitors (commercial protease inhibitor cocktail from Sigma), 
0.1 M PMSF (Sigma), 0.2 M DTT (Sigma), and 1% Triton X-100. 
Cell suspensions were frozen three times in liquid nitrogen and 
centrifuged at 20,000 g for 10 min. The resulting supernatants 
were removed and stored at −80°C. Protein concentrations were 
determined by the Bradford method and equal amounts of protein 
(30 or 60 µg) were used for immunoblotting. For the SDS-PAGE 
experiments samples were resolved by electrophoresis in SDS-
polyacrylamide gels and transferred to PVDF membranes. For the 
PAGE experiments samples were not boiled and were diluted 1:2 
in a sample buffer without SDS. Non-speciﬁ  c binding was blocked 
by gently agitating the membranes in 5% non-fat milk and 0.1% 
Tween in TBS for 1 h at room temperature. The blots were subse-
quently incubated with the respective primary antibodies over-
night at 4°C with gentle agitation (1:1,000 Polyclonal anti-a-syn 
antibody from Cell Signaling Technology, Inc., Danvers, MA, 
USA; 1:2,500 monoclonal anti-GAPDH antibody from Chemicon 
International; or 1:10,000 monoclonal anti-alpha-tubulin anti-
body from SIGMA).
Blots were washed with TBS containing 0.1% non fat milk and 
0.1% Tween three times (each time for 15 min), and then incubated 
with the appropriate horseradish peroxidase- conjugated second-
ary antibody for 2 h at room temperature with gentle   agitation. 
After three washes speciﬁ  c bands of   interest were detected by 
developing with an alkaline phosphatase enhanced chemical 
ﬂ  uorescence reagent (ECF, GE Healthcare, Buckinghamshire, 
England). Fluorescence signals were detected using a Biorad 
Versa-Doc Imager, and band densities were determined using 
Quantity One Software.
ISOLATION OF SOLUBLE AND POLYMERIC TUBULIN
To prepare soluble and polymeric tubulin fractions, cells were 
very gently washed twice with a microtubule stabilizing buffer 
(0.1 M N-morpholinoethanesulfonic acid, pH 6.75; 1 mM MgSO4; 
2 mM EGTA; 0.1 mM EDTA; 4 M glycerol). Soluble proteins were 
extracted for 4–6 min at 37°C in 100 µl of microtubule stabilizing 
buffer containing 0.1% Triton X-100. The remaining contents of 
the culture dish were scraped in 100 µl of 25 mM Tris (pH 6.8) 
and 0.5% SDS. This suspension was frozen three times in liquid 
nitrogen (Joshi and Cleveland, 1989). Protein concentrations for 
each sample were quantiﬁ  ed using the Bradford method.
DATA ANALYSIS
Each experimental endpoint for each cell line was run in dupli-
cate, and data are expressed as the mean ± SEM from at least three 
different measurements. P-values were calculated by one-way 
ANOVA, followed by a post hoc Dunnett’s or Bonferroni’s t test 
when appropriate.
RESULTS
ALPHA SYNUCLEIN OLIGOMERIZATION AND PROTEIN UBIQUINATION 
WERE INCREASED IN THE PD CYBRID CELLS
The PD cybrid cells and the control cybrid cells analyzed in this 
study were originally prepared and bioenergetically characterized as 
part of previously reported PD cybrid studies (Esteves et al., 2008, 
2009). PD cybrid lines used in this current study show a decrease of 
38% in complex I activity and of 28% in ATP levels when compared 
to the control cybrid lines (Esteves et al., 2008). In order to con-
ﬁ  rm the presence of protein aggregates we used antibodies (A11) 
that detect oligomeric proteins. A11 antibody staining was much 
stronger in the PD cell cells, suggesting it contained more oligo-
meric protein or proteins (Figure 1A). Moreover, we performed a 
PAGE western blot to detect if some of these oligomers were a-syn. 
We observed that the a-syn oligomer/monomer ratio was higher in 
the PD cybrid lines (Figures 1B,C), and the PD cybrid lines showed 
more protein ubiquination levels (Figure 1D). We also observed an 
increase in a-syn monomers levels detected by SDS-PAGE in PD 
cybrid lines as compared to CT cybrid cells (data not shown).
THE FREE TUBULIN/POLYMERIZED TUBULIN RATIO WAS INCREASED IN 
THE PD CYBRID
MT assembly requires ATP, therefore the reduction of PD cybrids 
ATP may interfere with the efﬁ  cacy of the polymerization/depolym-
erization process of tubulin. For that reason we immunocytochemi-
cally evaluated MT network integrity. MT networks were less well 
deﬁ  ned in the PD cybrid cells (Figure 2A), and the free/polymerized 
tubulin ratio was also elevated (Figures 2B,C). In the CT cybrid 
cells approximately one-third of the tubulin was in the free form, 
and in the PD cybrid approximately one-half of the tubulin was in Frontiers in Aging Neuroscience  www.frontiersin.org  January  2010 | Volume  1 | Article  5 | 3
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the free form (Table 1). Because of the viscosity of the polymerized 
tubulin all samples were corrected with GAPDH antibody in order 
to eliminate loading errors (Figures 2B,C).
TAXOL REDUCED TUBULIN AND ALPHA SYNUCLEIN ALTERATIONS IN PD 
CYBRID CELLS
Taxol stabilizes MT assemblies and reduces free tubulin/polymer-
ized tubulin ratios (Cragg and Newman, 2005). Before testing its 
effects in our cybrid model (which consists of undifferentiated, 
rapidly dividing cells) we determined 5 nM taxol did not com-
promise cell viability (data not shown). 5 nM taxol reduced the 
free tubulin/polymerized tubulin ratio in the PD cybrid lines but 
not in the control cybrid lines (Figures 3A,B). Taxol lowered a-syn 
oligomerization in PD cybrid cells but did not altered CT cybrid 
cells a-syn levels (Figures 3C,D). These results support the idea 
that MT depolymerization may potentiate the formation of oli-
gomeric a-syn.
DISCUSSION
We recently reported that mitochondrial ROS potentiates an 
increase in free tubulin levels, which is followed by a signiﬁ  cant 
increase of a-syn oligomers (Esteves et al., 2009). In order to fur-
ther clarify the relationship between mitochondrial metabolism 
and a-syn conformational change we now report studies per-
formed using two carefully characterized PD and CT cybrid cell 
lines. Our results corroborate and extend our previous ﬁ  nding that 
PD cybrids mitochondrial dysfunction induces a-syn oligomeriza-
tion, and suggest that microtubules may be a feasible therapeutic 
target to PD.
The cybrid approach has been used to model human 
  disease-specific mitochondrial dysfunction in PD. It has 
been described that in cybrid models such as the one used in 
these experiments changes in cell physiology likely arise as a 
consequence of and in response to mitochondrial function 
(Swerdlow, 2007).
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FIGURE 1 | Protein oligomerization in PD cybrids. (A) A11 staining is greater 
in the PD cybrids. Bars, 10 µm. (B) A western blot of alpha-synuclein monomer 
and oligomers in the PD and CT cybrid lines. (C) Densitometry analysis of alpha-
synuclein western blots showing the ratio between alpha-synuclein oligomer 
and monomer levels corrected for GAPDH. The ratio is increased in the PD 
cybrid line. (D) Ubiquitination densitometry analysis showed the PD cybrid cells 
had more ubiquitinated protein. **P < 0.01 and ***P < 0.001, signiﬁ  cantly 
different when compared to the CT cybrid lines.Frontiers in Aging Neuroscience  www.frontiersin.org  January  2010 | Volume  1 | Article  5 | 4
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We fully characterized a-syn aggregation in two PD cybrid cell 
lines. We demonstrated that compared to cells from two control 
cybrid cell lines, the PD cybrid cells had increased a-syn oligomeri-
zation, ubiquitination, and ﬁ  brillization.
If mitochondrial dysfunction does in fact promote a-syn oli-
gomerization, then it is necessary to elucidate the mechanisms 
that mediate this phenomenon. Our data support the hypothesis 
that free tubulin directly interacts with a-syn and promotes ﬁ  bril 
 formation  (Alim et al., 2002). While our data do not speciﬁ  cally 
elucidate how tubulin-a-syn interactions may physically promote 
oligomerization, they do provide a framework for developing 
further studies to address why a-syn oligomerization occurs 
in PD.
Taxol’s ability to reduce a-syn oligomerization in our experi-
ments suggests free tubulin can promote a-syn oligomerization. 
This does not preclude the possibility that a-syn oligomeriza-
tion might in turn disrupt tubulin polymerization (Chen et al., 
2007). It is therefore necessary to consider whether mitochondrial 
dysfunction supports a positive feedback loop in which mito-
chondrial dysfunction increases free tubulin levels, free tubulin 
increases a-syn oligomerization, and a-syn oligomers in turn fur-
ther elevate the free/polymerized tubulin ratio. a-Syn ﬁ  brillization 
requires it to transition from a ‘natively unfolded’ random coil to 
a beta-sheet structure. The beta sheet form then aggregates into 
oligomers, protoﬁ  brils, and eventually amyloid ﬁ  brils with cross-
beta structures (Shults, 2006). a-Syn polymerization is nucleation-
dependent and it is promoted by both tubulin and oxidative stress 
(Paik et al., 1999; Giasson et al., 2000; Souza et al., 2000; Paxinou 
et al., 2001; Sherer et al., 2002; Esteves et al., 2009).
Our data indicate for the ﬁ   rst time that taxol prevents 
  mitochondrial-mediated MT depolymerization and a-syn oli-
gomerization in cells that have dysfunctional mitochondria. These 
in vitro observations were made in cell lines with a neuronal back-
ground, and it will be interesting to see whether these ﬁ  ndings 
generalize to PD brains.
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FIGURE 2 | Tubulin alterations in the PD cybrid lines. (A) Tubulin 
immunocytochemistry reveals disruption of the microtubule network in the 
PD cybrid lines. (B) SDS-PAGE analysis shows that in the PD cybrids the free/
polymerized tubulin ratio is elevated. (C) After correcting for GADPH content 
the PD cybrids free/polymerized tubulin ratio was elevated as compared to the 
control cybrid cell line. **P < 0.01, signiﬁ  cantly different as compared to the 
CT cybrid lines. Bars, 10 µm.
Numerous cybrid studies using three different nuclear back-
grounds have shown PD cybrids have a sustained reduction of com-
plex I Vmax activity (Swerdlow et al., 1996, 1998; Gu et al., 1998; 
Esteves et al., 2008). In these studies biochemical data obtained 
from distinct, different cybrid cell lines were averaged and group 
means were comparable.
Table 1 | Percentage of free and polymerized tubulin.
  CT cybrids  PD cybrids
Free tubulin  36.41 ± 2.49  51.45 ± 2.86**#
Polymerized tubulin  63.59 ± 2.49***  48.55 ± 2.86*##
SDS-PAGE analysis demonstrated free and polymerized tubulin percentages 
differed between the PD cybrid lines and the CT cybrid lines. Results are 
expressed as the mean  ± SE  of  ﬁ   ve independent measurements. *P < 0.05, 
**P < 0.01, ***P < 0.001, signiﬁ  cantly different as compared to the CT cybrid’s 
free tubulin percentage. #P < 0.05, ##P < 0.01, signiﬁ  cantly different as compared 
to the CT cybrid’s polymerized tubulin percentage.Frontiers in Aging Neuroscience  www.frontiersin.org  January  2010 | Volume  1 | Article  5 | 5
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FIGURE 3 | Effects of taxol on tubulin and alpha synuclein. (A) SDS-PAGE 
showing the effect of 5 nM taxol on free/polymerized tubulin ratios. 
(B) Densitometry analysis indicated after correcting for GADPH content, 
5 nM taxol reduced the free/polymerized tubulin ratio in the PD but not the 
CT cybrid cells. (C) PAGE showing the effect of 5 nM taxol on 
alpha-synuclein oligomer levels. (D) Densitometry analysis indicated 5 nM 
taxol reduced alpha synuclein oligomer levels in the PD cybrid cells. 
**P < 0.01, signiﬁ  cantly different when compared to the untreated CT cybrid 
cells. #P < 0.05 and ##P < 0.01, signiﬁ  cantly different as compared to the 
untreated PD cybrid line.
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